Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial



Khanna, Dinesh, Denton, Christopher P, Jahreis, Angelika, van Laar, Jacob M, Frech, Tracy M, Anderson, Marina E, Baron, Murray, Chung, Lorinda, Fierlbeck, Gerhard, Lakshminarayanan, Santhanam
et al (show 14 more authors) (2016) Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. LANCET, 387 (10038). 2630 - 2640.

WarningThere is a more recent version of this item available.
[img] Text
101101617 SSc Ms rev FINAL Tracked.docx

Download (7MB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 11 May 2016 09:19
Last Modified: 25 Jan 2019 11:32
DOI: 10.1016/S0140-6736(16)00232-4
URI: http://livrepository.liverpool.ac.uk/id/eprint/3001199

Available Versions of this Item

Repository Staff Access